Cardiac ion channel trafficking defects and drugs.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pharmacology and Therapeutics

• Publication date

  2013-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.pharmthera.2013.03.008PMID 23558293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibiting the clathrin-mediated endocytosis pathway rescues KIR2.1 downregulation by pentamidine

  2013cited by this paper
• In Vitro Cardiovascular Effects of Dihydroartemisin-Piperaquine Combination Compared with Other Antimalarials

  2012cited by this paper
• Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?

  2012cited by this paper
• Molecular Determinants of Pentamidine-Induced hERG Trafficking Inhibition

  2012cited by this paper
• High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis

  2012cited by this paper
• Chronic Probucol Treatment Decreases the Slow Component of the Delayed-Rectifier Potassium Current in CHO Cells Transfected With KCNQ1 and KCNE1: A Novel Mechanism of QT Prolongation

  2012cited by this paper
• Involvement of Caveolin in Probucol-Induced Reduction in hERG Plasma-Membrane Expression

  2011cited by this paper
• Antidepressant-induced Ubiquitination and Degradation of the Cardiac Potassium Channel hERG*

  2011cited by this paper
• Hirsutenone directly blocks human ether-a-go-go related gene K+ channels.

  2011cited by this paper
• Progesterone Impairs Human Ether-a-go-go-related Gene (HERG) Trafficking by Disruption of Intracellular Cholesterol Homeostasis*

  2011cited by this paper
• Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

  2011cited by this paper
• Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.

  2011cited by this paper
• Interaction between the Cardiac Rapidly (IKr) and Slowly (IKs) Activating Delayed Rectifier Potassium Channels Revealed by Low K+-induced hERG Endocytic Degradation*

  2011cited by this paper
• Inhibition of lysosomal degradation rescues pentamidine-mediated decreases of K(IR)2.1 ion channel expression but not that of K(v)11.1.

  2011cited by this paper
• hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine

  2011cited by this paper
• hERG: protein trafficking and potential for therapy and drug side effects.

  2010cited by this paper
• Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine

  2010cited by this paper
• Sodium channel traffic on the cardiac microtubule highway.

  2010cited by this paper
• Tubulin polymerization modifies cardiac sodium channel expression and gating.

  2010cited by this paper
• Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking

  2010cited by this paper
• Rescue of mutated cardiac ion channels in inherited arrhythmia syndromes.

  2010cited by this paper
• Forward trafficking of ion channels: what the clinician needs to know.

  2010cited by this paper
• Involvement of Caveolin in Low K+-induced Endocytic Degradation of Cell-surface Human Ether-a-go-go-related Gene (hERG) Channels*

  2010cited by this paper
• Intracellular Potassium Stabilizes Human Ether-à-go-go-Related Gene Channels for Export from Endoplasmic Reticulum

  2009cited by this paper
• Antiarrhythmic drug‐induced internalization of the atrial specific K+ channel, Kv1.5

  2009cited by this paper
• Bepridil up‐regulates cardiac Na+ channels as a long‐term effect by blunting proteasome signals through inhibition of calmodulin activity

  2009cited by this paper
• Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents

  2009cited by this paper
• Lysosome mediated Kir2.1 breakdown directly influences inward rectifier current density.

  2008cited by this paper
• IKs response to protein kinase A-dependent KCNQ1 phosphorylation requires direct interaction with microtubules.

  2008cited by this paper
• Coexistence of hERG current block and disruption of protein trafficking in ketoconazole‐induced long QT syndrome

  2008cited by this paper
• Tubulin as a Binding Partner of the Heag2 Voltage-Gated Potassium Channel

  2008cited by this paper
• Drugs and trafficking of ion channels: a new pro‐arrhythmic threat on the horizon?

  2008cited by this paper
• Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer

  2007cited by this paper
• Cardiac Glycosides as Novel Inhibitors of Human Ether-a-go-go-Related Gene Channel Trafficking

  2007cited by this paper
• hERG channel trafficking: novel targets in drug-induced long QT syndrome.

  2007cited by this paper
• Identification of IKr and Its Trafficking Disruption Induced by Probucol in Cultured Neonatal Rat Cardiomyocytes

  2007cited by this paper
• Mechanisms of cardiac potassium channel trafficking

  2007cited by this paper
• Cellular basis for triggered ventricular arrhythmias that occur in the setting of compensated hypertrophy and heart failure: considerations for diagnosis and treatment.

  2007cited by this paper
• Cardiotoxicity of antimalarial drugs.

  2007cited by this paper
• Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.

  2006cited by this paper
• Drug‐induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine

  2006cited by this paper
• Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism

  2006cited by this paper
• Chronic Inhibition of Cardiac Kir2.1 and hERG Potassium Channels by Celastrol with Dual Effects on Both Ion Conductivity and Protein Trafficking*♦

  2006cited by this paper
• Pentamidine reduces hERG expression to prolong the QT interval

  2005cited by this paper
• Molecular physiology of cardiac repolarization.

  2005cited by this paper
• Protein trafficking abnormalities: a new mechanism in drug‐induced long QT syndrome

  2005cited by this paper
• HERG-Lite: a novel comprehensive high-throughput screen for drug-induced hERG risk.

  2005cited by this paper
• Mechanisms of arsenic-induced prolongation of cardiac repolarization.

  2004cited by this paper
• Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent

  2004cited by this paper
• Seizures and prolonged QTc with atomoxetine overdose.

  2004cited by this paper
• Role of the Cytosolic Chaperones Hsp70 and Hsp90 in Maturation of the Cardiac Potassium Channel hERG

  2003cited by this paper
• Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death

  2003cited by this paper
• Unusual Effects of a QT-Prolonging Drug, Arsenic Trioxide, on Cardiac Potassium Currents

  2003cited by this paper
• Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve

  2002cited by this paper
• The Binding Site for Channel Blockers That Rescue Misprocessed Human Long QT Syndrome Type 2 ether-a-gogo-related Gene (HERG) Mutations*

  2002cited by this paper
• Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia

  2000cited by this paper
• Effect of the microtubule polymerizing agent taxol on contraction, Ca2+ transient and L‐type Ca2+ current in rat ventricular myocytes

  1999cited by this paper
• Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators*

  1997cited by this paper
• Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.

  1986cited by this paper
• Clinical Pharmacokinetics of Amiodarone

  1984cited by this paper
• Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.

  1983cited by this paper
• [Plasma levels of probucol in man after single and repeated oral doses (author's transl)].

  1980cited by this paper

• Ion channel traffic jams: the significance of trafficking deficiency in long QT syndrome

  2025influential citation
• High Throughput Screening Identifies a Small Molecule Trafficking Corrector for Long-QT Syndrome Associated KCNQ1 Variants

  2025cites this paper
• Rab11 participated in the chronic effect of AngII on the IKs current and KCNQ1 channel protein expression

  2025cites this paper
• The Kv4 potassium channel modulator NS5806 attenuates cardiac hypertrophy in vivo and in vitro

  2024cites this paper
• The network of cardiac KIR2.1: its function, cellular regulation, electrical signaling, diseases and new drug avenues

  2024influential citation
• In silico analysis of the dynamic regulation of cardiac electrophysiology by Kv11.1 ion‐channel trafficking

  2023influential citation
• Chronic Propafenone Application Increases Functional KIR2.1 Expression In Vitro

  2023cites this paper
• Deacetylation mechanism and potential reversal strategy of long QT syndrome on hERG K+ channel under hypoxia.

  2022cites this paper
• Empagliflozin and Dapagliflozin Increase Na+ and Inward Rectifier K+ Current Densities in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells (hiPSC-CMs)

  2022cites this paper
• Uremic toxins in chronic kidney disease highlight a fundamental gap in understanding their detrimental effects on cardiac electrophysiology and arrhythmogenesis

  2022cites this paper
• The Challenges of Predicting Drug-Induced QTc Prolongation in Humans

  2022cites this paper
• Specific protein kinase C isoform exerts chronic inhibition on the slowly activating delayed-rectifier potassium current by affecting channel trafficking

  2021cites this paper
• LUF7244 plus Dofetilide Rescues Aberrant Kv11.1 Trafficking and Produces Functional IKv11.1

  2020cites this paper
• Drug-likeness of linear pentamidine analogues and their impact on the hERG K+ channel – correlation with structural features

  2019cites this paper
• Molecular Regulation of Cardiac Inward Rectifier Potassium Channels by Pharmacological Agents

  2018cites this paper
• Editorial: Ion Channel Trafficking and Cardiac Arrhythmias

  2018cites this paper
• Class III antiarrhythmic drugs amiodarone and dronedarone impair KIR2.1 backward trafficking

  2017cites this paper
• The molecular basis of chloroethylclonidine block of inward rectifier (Kir2.1 and Kir4.1) K^+ channels

  2016cites this paper
• A 2015 focus on preventing drug-induced arrhythmias

  2016influential citation
• Identification of drug targets related to the induction of ventricular tachyarrhythmia through a systems chemical biology approach.

  2015cites this paper
• Protein trafficking in cardiovascular disease: How the science has evolved and where it must go.

  2015cites this paper
• 13th Annual Meeting of the Safety Pharmacology Society: focus on novel technologies and safety pharmacology frontiers

  2014cites this paper
• Protective role of adiponectin in volume overload-induced heart failure

  2014cites this paper
• Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue.

  2013cites this paper